HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancras C W Hogendoorn Selected Research

Enchondromatosis (Ollier Disease)

9/2005cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
3/2005Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
12/2004Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pancras C W Hogendoorn Research Topics

Disease

67Neoplasms (Cancer)
01/2019 - 07/2003
33Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 05/2004
20Sarcoma (Soft Tissue Sarcoma)
07/2017 - 07/2004
20Chondrosarcoma
04/2013 - 02/2004
15Ewing Sarcoma (Sarcoma, Ewing)
01/2017 - 05/2004
10Neoplasm Metastasis (Metastasis)
10/2021 - 08/2005
6Carcinoma (Carcinomatosis)
07/2021 - 01/2011
6Breast Neoplasms (Breast Cancer)
10/2017 - 02/2004
6Paraganglioma (Paragangliomas)
11/2015 - 04/2004
6Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013 - 08/2005
5Chondroma (Enchondroma)
07/2021 - 03/2004
5Carcinogenesis
11/2012 - 09/2005
5Osteochondroma (Osteocartilaginous Exostosis)
01/2012 - 04/2005
4Fibroma (Fibromatosis)
05/2014 - 06/2005
4Hypoxia (Hypoxemia)
07/2010 - 01/2007
3Genomic Instability
10/2021 - 09/2007
3Osteoblastoma
01/2013 - 01/2010
3Enchondromatosis (Ollier Disease)
09/2005 - 12/2004
2Infections
08/2021 - 10/2016
2Giant Cell Tumor of Bone
01/2019 - 08/2004
2Neurofibrosarcoma (MPNST)
01/2016 - 01/2010
2Pheochromocytoma
11/2015 - 11/2009
2Disease Progression
07/2015 - 04/2010
2Synovial Sarcoma (Synovioma)
08/2014 - 01/2010
2Febrile Neutropenia
04/2014 - 07/2007
2Neutropenia
04/2014 - 07/2007
2Chordoma
11/2012 - 02/2011
2Inflammation (Inflammations)
06/2012 - 04/2003
2Mesenchymal Chondrosarcoma
02/2012 - 03/2008
2Multiple Hereditary Exostoses (Hereditary Multiple Exostoses)
01/2012 - 06/2011
2Myxoid Liposarcoma
12/2010 - 09/2010
2Aneuploidy (Aneuploid)
06/2009 - 07/2003
1Albuminuria
03/2022
1Tuberculosis (Tuberculoses)
08/2021

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
08/2021 - 03/2004
12Doxorubicin (Adriamycin)FDA LinkGeneric
07/2017 - 01/2007
11Messenger RNA (mRNA)IBA
11/2015 - 11/2005
10DNA (Deoxyribonucleic Acid)IBA
11/2015 - 07/2003
8Biological ProductsIBA
10/2017 - 07/2004
8Transcription Factors (Transcription Factor)IBA
11/2012 - 04/2006
7Phosphotransferases (Kinase)IBA
11/2015 - 08/2009
7Imatinib Mesylate (Gleevec)FDA Link
01/2013 - 08/2005
6Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2004
6Pharmaceutical PreparationsIBA
10/2017 - 08/2011
6IfosfamideFDA LinkGeneric
07/2017 - 07/2007
5EnzymesIBA
03/2022 - 11/2005
5Histones (Histone)IBA
10/2021 - 06/2012
5Peptides (Polypeptides)IBA
01/2017 - 08/2009
5Cisplatin (Platino)FDA LinkGeneric
10/2016 - 01/2007
4RNA (Ribonucleic Acid)IBA
01/2017 - 05/2009
4Succinate Dehydrogenase (Fumarate Reductase)IBA
11/2015 - 05/2004
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2015 - 08/2009
4ParaffinIBA
10/2012 - 06/2009
4ErbB Receptors (EGF Receptor)IBA
01/2012 - 05/2004
4Keratins (Keratin)IBA
07/2011 - 12/2003
3Chemokine ReceptorsIBA
01/2017 - 04/2003
3Insulin-Like PeptidesIBA
01/2016 - 07/2010
3beta CateninIBA
01/2013 - 09/2005
3Estrogens (Estrogen)FDA Link
07/2011 - 09/2005
3Tyrosine Kinase InhibitorsIBA
01/2011 - 08/2010
3Dasatinib (BMS 354825)FDA Link
09/2010 - 08/2009
3LuciferasesIBA
01/2010 - 02/2007
2GlycosaminoglycansIBA
11/2019 - 06/2011
2Methotrexate (Mexate)FDA LinkGeneric
10/2016 - 07/2015
2Indicators and Reagents (Reagents)IBA
01/2016 - 03/2012
2ChromatinIBA
01/2016 - 01/2009
2Fumarate Hydratase (Fumarase)IBA
11/2015 - 09/2007
2Small Interfering RNA (siRNA)IBA
11/2015 - 09/2009
2Brachyury protein (Brachyury)IBA
11/2012 - 02/2011
2Formaldehyde (Formol)FDA Link
10/2012 - 06/2009
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2012 - 03/2009
2Aromatase (CYP19)IBA
07/2011 - 11/2005
2exemestane (Aromasin)FDA Link
07/2011 - 11/2005
2Mucin-1 (CA 15-3 Antigen)IBA
07/2011 - 06/2010
2Proteoglycans (Proteoglycan)IBA
06/2011 - 03/2011
2GlypicansIBA
06/2011 - 03/2011
2LigandsIBA
04/2011 - 09/2008
2Natural Killer Cell ReceptorsIBA
04/2011 - 09/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2011 - 09/2010
2Cyclin-Dependent Kinase 4IBA
07/2010 - 07/2006
2Matrix Metalloproteinases (MMPs)IBA
07/2010 - 04/2010
2Cyclin D1IBA
09/2009 - 09/2005
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2007 - 10/2006
2Peptide Hydrolases (Proteases)FDA Link
01/2007 - 08/2004
2Estrogen ReceptorsIBA
11/2005 - 02/2004
2OligonucleotidesIBA
12/2004 - 05/2004
2ChemokinesIBA
05/2003 - 04/2003
1mifamurtideIBA
06/2022
1Myeloid Differentiation Factor 88IBA
08/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2021

Therapy/Procedure

29Therapeutics
06/2022 - 11/2005
26Drug Therapy (Chemotherapy)
01/2019 - 08/2003
8Radiotherapy
10/2017 - 08/2005
4Curettage
07/2021 - 03/2008
3Transplantation
07/2013 - 12/2005
3Adjuvant Chemotherapy
10/2012 - 02/2010
2Immunotherapy
01/2016 - 01/2012
2Aftercare (After-Treatment)
07/2012 - 09/2010
2Bone Transplantation (Bone Grafting)
07/2012 - 01/2011
2Ligation
12/2010 - 03/2007